EVR Research’s Enfusion, Inc. ENFN Stock Holding History

EVR Research’s Portfolio ENFN Stock Details ENFN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-400,000	Closed	-$4.12M	–	51
2024 Q4	$4.12M	Buy	+400,000	New	+$3.87M	1.38%	23

Other funds holding ENFN

FMC

FTV Management Company San Francisco, California $541M AUM 34.37% 1-Year Est. Return

Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

LECM

Lead Edge Capital Management New York $408M AUM 4.05% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

EVR Research's ENFN Position: Q1 2025 in Review

EVR Research sold out of Enfusion, Inc. (ENFN) in Q1 2025, closing a stake of 400,000 shares — an estimated $4.12M sold.

EVR Research first reported a position in ENFN in Q4 2024 and held it in 1 quarter. The position peaked at $4.12M in Q4 2024. 132 funds tracked by Wall St. Rank hold ENFN as of Q1 2025.

EVR Research reported no remaining Enfusion, Inc. position as of Q1 2025 after selling out during the quarter.
EVR Research sold 400,000 Enfusion, Inc. shares in Q1 2025, an estimated $4.12M.
EVR Research first reported a position in Enfusion, Inc. in Q4 2024 and held it in 1 quarter.
EVR Research's Enfusion, Inc. position peaked at $4.12M in Q4 2024.
132 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q1 2025.

Based on EVR Research's 13F filing for Q1 2025, filed 14 May 2025.